Clinical Trial Update: Donor Enhancement With Plerixafor Post Myeloablative Allogeneic Transplant [Phase 1, Phase 2]

View source ↗

Summary

Phase 1/2 trial evaluating donor enhancement with plerixafor after myeloablative allogeneic stem cell transplantation; the study is completed and results have b…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Bone Marrow Graft Failure

Drugs mentioned

• Plerixafor (Plerixafor)

Snippet

Sponsor: Mitchell Horwitz, MD | Conditions: Failure of Bone Marrow Graft | Phase 1, Phase 2 | Status: COMPLETED | Results posted: 2015-11-26